News
- Author:
- Bruce Jancin
Publish date: January 5, 2021
CTP-543, a selective JAK1/2 inhibitor, aims to fill unmet need.
News
- Author:
- Bruce Jancin
Publish date: December 29, 2020
“Judicious use of molecular studies may help in establishing the diagnosis, but I don’t think any one molecular study is ever going to be our home ...
News
- Author:
- Bruce Jancin
Publish date: December 22, 2020
Safety and efficacy of home narrow-band UVB phototherapy match office-based UVB, but with greater patient convenience.
News
- Author:
- Bruce Jancin
Publish date: December 2, 2020
Research attention is focusing on role of circulating IgE-activated basophils.
News
- Author:
- Bruce Jancin
Publish date: December 2, 2020
The fixed-dose combination of benzoyl peroxide and tretinoin is under FDA review.
News
- Author:
- Bruce Jancin
Publish date: December 2, 2020
“Prevention is low cost, low risk, and effective.”
News
- Author:
- Bruce Jancin
Publish date: December 1, 2020
“What we came up with is a very sensible approach to defining whether patients should get either topical or systemic therapy.”
News
- Author:
- Bruce Jancin
Publish date: November 30, 2020
“The guidelines don’t give full credit to the anti–IL-17 agents.”
News
- Author:
- Bruce Jancin
Publish date: November 30, 2020
“My prediction is apremilast will have efficacy in children and teenagers comparable to what it has in adults.”
News
- Author:
- Bruce Jancin
Publish date: November 23, 2020
In one study, the mean Eczema Area and Severity Index score in those initially randomized to merino wool improved from a mean baseline of 4.5 to 1....
News
- Author:
- Bruce Jancin
Publish date: November 23, 2020
The One-Month DAPT trial swapped aspirin monotherapy for prolonged P2Y12 inhibition.
News
- Author:
- Bruce Jancin
Publish date: November 19, 2020
Key insight: the relationship between mitotic rate and melanoma survival is nonlinear.
News
- Author:
- Bruce Jancin
Publish date: November 19, 2020
The rapidity of response was noteworthy in these steroid-refractory patients.
News
- Author:
- Bruce Jancin
Publish date: November 19, 2020
Few left long-term extension study because of adverse events or loss of efficacy.
News
- Author:
- Bruce Jancin
Publish date: November 19, 2020
“Inadequate treatment for metabolic syndrome was found to be a mortality predictor while on clozapine therapy,” said Dr. Sharon Taub.
